Skip to main content
. 2022 Feb 18;24(1):61–69. doi: 10.1007/s11920-022-01321-8

Table 1.

Overview of each neuromodulation technique for EDs

Non-invasive neuromodulation Strengths Weaknesses

Repetitive transcranial magnetic stimulation (rTMS)

Electromagnetic coil is used to modulate cortical excitability in a target brain region, e.g. DLPFC

• Minimal adverse effects

• Safe and well-tolerated in EDs

• Evidence for benefits in BMI, ED and mood symptoms in SE-AN

• Evidence for cognitive benefits across EDs

• Time-intensive, 20–30 sessions for optimal effects

• Heterogeneity in response

• Optimal parameters yet to be determined

• Small evidence base in BED and BN

• Cost-effectiveness yet to be determined

Transcranial direct current stimulation (tDCS)

Applies weak direct current to the scalp to modulate existing neuronal activity

• Ease of use and minimal adverse effects

• Safe and well-tolerated in EDs

• Can be used “online” and applied at-home

• Evidence for short-term benefits in cognition and ED symptoms

• Low-cost treatment

• Few studies have applied tDCS therapeutically (i.e. > 5 sessions)

• Lack of RCTs across EDs

Transcutaneous auricular vagus nerve stimulation (taVNS)

Attached to the auricular concha and delivers electrical stimulation at the subcutaneous course of the vagus nerve

• Non-invasive alternative to surgical VNS

• Can be delivered at-home

• Low-cost treatment

• Small evidence base in psychiatric disorders, with only one case series in EDs

Electroconvulsive therapy (ECT)

Performed under general anaesthesia using electrical stimulation to the scalp to induce a generalised tonic–clonic seizure

• May have positive effects on comorbid mood symptoms

•Effect on weight unclear “last resort” treatment option

• Adverse effects, e.g. cognition and memory

• Not a long-term treatment option

• No RCTs to show clinical efficacy in AN

• Not associated with improvement in ED symptoms

Invasive neuromodulation

Deep brain stimulation (DBS)

Electrical impulses are delivered to illness-relevant brain regions via implanted electrodes

• Preliminary success for improving BMI, ED and affective symptoms in SE-AN

• Relatively safe in the short- and long-term

• Focal stimulation

• Targets subcortical regions that are inaccessible with other neuromodulation techniques

• Adverse side effects (e.g. infection) may be over-represented in SE-AN

• Requires neurosurgery

• Close monitoring or follow-up is essential which patients may find burdensome

• Switching the device off could lead to deterioration of symptoms (i.e. not reversible)

• Expensive treatment